Impotence News and Research

RSS
Erectile dysfunction, sometimes called "impotence," is the repeated inability to get or keep an erection firm enough for sexual intercourse. The word "impotence" may also be used to describe other problems that interfere with sexual intercourse and reproduction, such as lack of sexual desire and problems with ejaculation or orgasm. Using the term erectile dysfunction makes it clear that those other problems are not involved.
PSA screening shows low-grade prostate cancers do not progress to higher grade over time

PSA screening shows low-grade prostate cancers do not progress to higher grade over time

Weekend reading: Mental illness stigma, health insurance mazes and female libido

Weekend reading: Mental illness stigma, health insurance mazes and female libido

Study shows brachytherapy is underused in the UK

Study shows brachytherapy is underused in the UK

New review of medications to prevent migraines appears in Journal of General Internal Medicine

New review of medications to prevent migraines appears in Journal of General Internal Medicine

Researchers study effectiveness of intermittent therapy for prostate cancer treatment

Researchers study effectiveness of intermittent therapy for prostate cancer treatment

Focal laser ablation uses targeted heat to burn away cancerous cells in prostate

Focal laser ablation uses targeted heat to burn away cancerous cells in prostate

Periodontal disease may predispose men to impotence

Periodontal disease may predispose men to impotence

ARCHITECT 2nd Generation Testosterone Assay from Abbott

ARCHITECT 2nd Generation Testosterone Assay from Abbott

Men with prostate cancer can benefit from active surveillance

Men with prostate cancer can benefit from active surveillance

FDA accepts Sunovion’s two LATUDA sNDAs for review

FDA accepts Sunovion’s two LATUDA sNDAs for review

New prostate cancer therapy triggers questions about cost, effectiveness and safety

New prostate cancer therapy triggers questions about cost, effectiveness and safety

First Edition: October 29, 2012

First Edition: October 29, 2012

National Proactive Surveillance Network launches today

National Proactive Surveillance Network launches today

Abbott receives CE Marking for ARCHITECT testosterone assay

Abbott receives CE Marking for ARCHITECT testosterone assay

Many men with metastatic prostate cancer live longer on continuous hormone therapy

Many men with metastatic prostate cancer live longer on continuous hormone therapy

Doctors disagree on new prostate cancer screening guidelines

Doctors disagree on new prostate cancer screening guidelines

PSA test benefits are questionable, yet physicians struggle to stop them

PSA test benefits are questionable, yet physicians struggle to stop them

Federal task force recommends dropping routine prostate cancer test

Federal task force recommends dropping routine prostate cancer test

TJU researchers to investigate Cu-64 imaging agent for prostate cancer

TJU researchers to investigate Cu-64 imaging agent for prostate cancer

Sunovion announces results from LATUDA open-label study for schizophrenia

Sunovion announces results from LATUDA open-label study for schizophrenia